Hyo Rak Lee

Simvastatin plus capecitabine–cisplatin versus placebo plus capecitabine–cisplatin in patients with previously untreated advanced gastric cancer: A double-blind randomised phase 3 study

Seung Tae Kim, Jung Hun Kang, Jeeyun Lee et al. · European Journal of Cancer · 2014 · 107 citations

Gastrointestinal Oncology, Medicine, Advanced Gastric Cancer +7

A multi-center, open-label, randomized phase III trial of first-line chemotherapy with capecitabine monotherapy versus capecitabine plus oxaliplatin in elderly patients with advanced gastric cancer

In Gyu Hwang, Jun Ho Ji, Jung Hun Kang et al. · Journal of Geriatric Oncology · 2017 · 46 citations

Surgical Oncology, Oncology, Elderly Patients +7

Docetaxel Plus Cisplatin as Second-Line Therapy in Metastatic or Recurrent Advanced Gastric Cancer Progressing on 5-Fluorouracil-Based Regimen

Se Hoon Park, Won Ki Kang, Hyo Rak Lee et al. · American Journal of Clinical Oncology · 2004 · 45 citations

Multicenter phase III trial of S-1 and cisplatin versus S-1 and oxaliplatin combination chemotherapy for first-line treatment of advanced gastric cancer (SOPP trial)

Keun-Wook Lee, Ik‐Joo Chung, Min‐Hee Ryu et al. · Gastric Cancer · 2020 · 43 citations · Full text

Surgical Oncology, Cisplatin Versus S-1, Gastrointestinal Oncology +7

Cytogenetic biodosimetry for Fukushima travelers after the nuclear power plant accident: no evidence of enhanced yield of dicentrics

Jin Kyung Lee, Eun-Ae Han, Seung‐Sook Lee et al. · Journal of Radiation Research · 2012 · 37 citations · Full text

Engineering, Cytogenetics, Genetics +20